An interventional study of Iyengar Yoga and Socialization Control in Prolonged Grief Disorder, sponsored by Medical College of Wisconsin. Active, not recruiting at 1 site in United States. Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Prolonged Grief Disorder with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Prolonged Grief Disorder · United States.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, this one is the 6th largest by enrollment of the 14 interventional ones that give a count, is one of 3 that started in 2021, is one of 10 with no phase, and was the 8th registered.
40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.
Browse Prolonged Grief Disorder studies →4 of the 15 studies in Prolonged Grief Disorder with a site in United States are open now. Recruiting first, the newest first:
University of Virginia · Sites in United States
Ages 18–65 · Healthy volunteers
RAND · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 8+
Medical College of Wisconsin · Sites in United States
Ages 40–89
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Prolonged Grief Disorder studies recruiting now, 7 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 40 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 68 is close to the median of 73 across 36 interventional studies indexed under Prolonged Grief Disorder.
Median enrollment 42 across the 14 interventional studies, 0 across the 1 observational. Of the 7 that completed or were terminated, 3 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 10 most frequent:
Medical College of Wisconsin is the lead sponsor of 550 studies on the registry; 123 are open to participants now.
Of its 76 completed or terminated interventional studies of FDA-regulated products, 58 (76%) have results posted.
Medical College of Wisconsin has 2 studies filed under Prolonged Grief Disorder — fewer than ten, so there is no comparison to draw.
3 of the studies in Prolonged Grief Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05026827Medical College of WisconsinIyengar Yoga for Prolonged Grief Disorder | 2026-12 |
| NCT07318090University of PittsburghF-PGT - Prolonged Grief Treatment for Families Affected by Suicide | 2026-12-31 |
| NCT06724289University of VirginiaPsilocybin for Prolonged Grief Disorder | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Experiencing the death of a loved one is inevitable for older adults. Before the coronavirus disease 2019 (COVID-19) pandemic, over 2.5 million people died annually in the United States, including 52,000 in Wisconsin alone, and COVID-19 has added to this toll. Each person who dies leaves an average of five grieving people behind. Most grieving older adults are resilient and recover their pre-loss functioning within one year. However, in about 10%, acute grief becomes protracted and debilitating, leading to the development of prolonged grief disorder (PGD), a clinically diagnosable mental health condition. PGD in older adults increases the risk for poorer medical, mental health, and cognitive outcomes; lower quality of life; disability; premature mortality; and suicide. Despite the magnitude of this problem, the neurobiology of PGD in older adults is poorly understood. By using Iyengar Yoga (IY) as a probe for PGD neurobiology, this pilot project aims to address this critical gap.
Our goal is to conduct a pilot study to examine in PGD the modulating effects of 10-week IY on circulating endocannabinoid and emotion processing brain circuit, and the associations between biological changes and clinical response.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will engage in 10 weekly IY classes
Other: Iyengar Yoga
Participants will engage in 10 weekly socialization control group sessions
Other: Socialization Control
A group of participants will also be followed for 10 weeks
Participation in Iyengar Yoga classes
Participation in socialization control group sessions
Change in circulating endocannabinoid concentrations
Change in circulating endocannabinoids from baseline to post-intervention
Time frame: 10 weeks
Change in neural activity measured using Functional magnetic resonance imaging (fMRI)
Change in neural activity from baseline to post-intervention
Time frame: 10 weeks
Inventory of Complicated Grief (ICG) scale score change
ICG score ranges from 0 to 76 (higher scores indicate worse outcome)
Time frame: 10 weeks
Plan to share: No
Started Aug 2021 (actual). Primary completion is estimated for Dec 2026, 64 months after the start.
Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 64 months is above that.
Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Oct 9, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical College of Wisconsin →